Back to Search
Start Over
Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem
- Source :
- Fertility and Sterility. 100:1270-1276.e3
- Publication Year :
- 2013
- Publisher :
- Elsevier BV, 2013.
-
Abstract
- Objective To explore the utility of using the ratio between oocyte yield and total dose of FSH, i.e., the ovarian sensitivity index (OSI), to define ovarian response patterns. Design Retrospective cross-sectional study. Setting University-affiliated private center. Patient(s) The entire unselected cohort of 7,520 IVF/intracytoplasmic sperm injection treatments (oocyte pick-ups [OPUs]) during an 8-year period (long GnRH agonist–recombinant FSH protocol). Intervention(s) None. Main Outcome Measure(s) The distribution of the OSI (oocytes recovered × 1,000/total dose of FSH), the cutoff levels for poor and high response, set at ±1 SD, and the relationship between OSI and treatment outcome. Result(s) OSI showed a log-normal distribution with cutoff levels for poor and high response at 1.697/IU and 10.07/IU, respectively. A nomogram is presented. Live-birth rates per OPU were 10.5 ± 0.1%, 26.9 ± 0.6%, and 36.0 ± 1.4% for poor, normal, and high response treatments, respectively. The predictive power (C-statistic) for OSI to predict live birth was superior to that of oocyte yield. Conclusion(s) The OSI improves the definition of ovarian response patterns because it takes into account the degree of stimulation. The nomogram presents evidence-based cutoff levels for poor, normal, and high response and could be used for unifying study designs involving ovarian response patterns.
- Subjects :
- Adult
Ovulation
medicine.medical_specialty
Pregnancy Rate
medicine.drug_class
medicine.medical_treatment
Oocyte Retrieval
Fertilization in Vitro
Controlled ovarian hyperstimulation
Buserelin
Chorionic Gonadotropin
Drug Administration Schedule
Intracytoplasmic sperm injection
Gonadotropin-Releasing Hormone
Nafarelin
Ovarian Hyperstimulation Syndrome
Ovulation Induction
Pregnancy
Risk Factors
Gonadotropin-releasing hormone agonist
medicine
Humans
Cutoff
Retrospective Studies
Gynecology
business.industry
Ovary
Obstetrics and Gynecology
Fertility Agents, Female
Nomogram
Oocyte
Recombinant Proteins
Nomograms
Cross-Sectional Studies
Logistic Models
Treatment Outcome
medicine.anatomical_structure
Reproductive Medicine
Cohort
Drug Therapy, Combination
Female
Follicle Stimulating Hormone, Human
Live birth
business
Live Birth
Subjects
Details
- ISSN :
- 00150282
- Volume :
- 100
- Database :
- OpenAIRE
- Journal :
- Fertility and Sterility
- Accession number :
- edsair.doi.dedup.....f8744f535433e782904a982b8f0bf985